Decline in Births and Rise in Deaths in the U.S. from 2010 to 2023

Between 2010 and 2023, the U.S. saw a decline in birth rates and a rise in death rates, reflecting significant demographic changes over the period. Learn more about the trends and their implications.
Between 2010 and 2023, the United States experienced a significant demographic shift characterized by a decline in birth rates and an increase in death rates. According to the August 27, 2025, report from the National Vital Statistics Reports published by the National Center for Health Statistics, the number of births decreased by approximately 10% over this period. Birth rates remained relatively stable from 2010 to 2016, then declined sharply from 2016 to 2019, before fluctuating through 2023. Conversely, the number of deaths increased by about 25%, with a notable rise from 2010 to 2019 and fluctuations thereafter.
Specifically, the crude birth rate dropped by 18%, with annual decreases of roughly 0.8% from 2010 to 2015 and 2.0% from 2015 to 2019; after that, the rates fluctuated. The death rate, on the other hand, rose by 15% during the same period. The ratio of births to deaths decreased by 28%, falling by an average of 1.6% annually before 2019 and then fluctuating afterwards. These trends were particularly evident across the three largest racial and Hispanic-origin groups, with the gap narrowing over time, especially during and after the COVID-19 pandemic.
Researchers from the National Center for Health Statistics, including Dr. Brady E. Hamilton, analyzed these shifts, highlighting their implications for population dynamics and public health. The findings suggest evolving demographic patterns influenced by factors such as healthcare, socio-economic conditions, and the pandemic’s impact. For more detailed information, visit the full report available at the CDC website.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Five-Year Follow-Up Shows Enzalutamide Extends Survival in Men with Advanced Prostate Cancer
A five-year follow-up of the ARCHES study reveals that combining enzalutamide with hormone therapy significantly extends survival in men with metastatic hormone-sensitive prostate cancer, offering new hope for improved treatment outcomes.
The Vital Impact of Community and Family Support on Health Behavior Change and Outcomes
Research highlights the critical role of community and family support in changing health behaviors and reducing cardiovascular disease risk among Latino populations through culturally tailored interventions and systemic improvements.
High-markup Hospitals Have Worse Patient Outcomes Despite Higher Charges
A new UCLA study reveals that hospitals with higher charges often have poorer patient outcomes, highlighting the need for transparency and regulation in healthcare pricing.
Wegovy Associated with Reduced Heart Risks Compared to Similar Medications, New Study Finds
A new study suggests that Wegovy may lower the risk of heart attack and stroke more effectively than similar obesity medications, highlighting its potential cardiovascular benefits.



